These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 30363474)
21. Non-motor symptoms and quality of life in tremor dominant vs postural instability gait disorder Parkinson's disease patients. Wu Y; Guo XY; Wei QQ; Ou RW; Song W; Cao B; Zhao B; Shang HF Acta Neurol Scand; 2016 May; 133(5):330-7. PubMed ID: 26195131 [TBL] [Abstract][Full Text] [Related]
22. Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson's disease. Li H; Zhang M; Chen L; Zhang J; Pei Z; Hu A; Wang Q Mov Disord; 2010 Dec; 25(16):2740-6. PubMed ID: 20945434 [TBL] [Abstract][Full Text] [Related]
23. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. Müller J; Kemmler G; Wissel J; Schneider A; Voller B; Grossmann J; Diez J; Homann N; Wenning GK; Schnider P; Poewe W; J Neurol; 2002 Jul; 249(7):842-6. PubMed ID: 12140667 [TBL] [Abstract][Full Text] [Related]
24. Longitudinal predictors of health-related quality of life in isolated dystonia. Junker J; Hall J; Berman BD; Vidailhet M; Roze E; Bäumer T; Malaty IA; Shukla AW; Jankovic J; Reich SG; Espay AJ; Duque KR; Patel N; Perlmutter JS; Jinnah HA; ; Brandt V; Brüggemann N J Neurol; 2024 Feb; 271(2):852-863. PubMed ID: 37839041 [TBL] [Abstract][Full Text] [Related]
26. Determinants of the quality of life in Parkinson's disease: results of a cohort study from Southwest China. Wu Y; Guo XY; Wei QQ; Song W; Chen K; Cao B; Ou RW; Zhao B; Shang HF J Neurol Sci; 2014 May; 340(1-2):144-9. PubMed ID: 24679837 [TBL] [Abstract][Full Text] [Related]
27. Effect of botulinum toxin type A on non-motor symptoms and quality of life in Meige syndrome. Zheng H; Wu L; Tian S; Liu M; Zhan Q; Yu X; Xie Y; Zhong X; Wu W Front Neurol; 2023; 14():1115482. PubMed ID: 36846150 [TBL] [Abstract][Full Text] [Related]
28. Assessment of Non-Motor Symptoms of Parkinson's Disease and Their Impact on the Quality of Life: An Observatiobnal Study. Kumar A; Patil S; Singh VK; Pathak A; Chaurasia RN; Mishra VN; Joshi D Ann Indian Acad Neurol; 2022; 25(5):909-915. PubMed ID: 36561034 [TBL] [Abstract][Full Text] [Related]
29. Randomised controlled trial of escitalopram for cervical dystonia with dystonic jerks/tremor. Zoons E; Booij J; Delnooz CCS; Dijk JM; Dreissen YEM; Koelman JHTM; van der Salm SMA; Skorvanek M; Smit M; Aramideh M; Bienfait H; Boon AJW; Brans JWM; Hoogerwaard E; Hovestadt A; Kamphuis DJ; Munts AG; Speelman JD; Tijssen MAJ J Neurol Neurosurg Psychiatry; 2018 Jun; 89(6):579-585. PubMed ID: 29326295 [TBL] [Abstract][Full Text] [Related]
30. Frequency and Dynamics of Non-motor Symptoms Presentation in Hispanic Patients With Parkinson Disease. Sánchez-Martínez CM; Choreño-Parra JA; Placencia-Álvarez N; Nuñez-Orozco L; Guadarrama-Ortiz P Front Neurol; 2019; 10():1197. PubMed ID: 31798522 [TBL] [Abstract][Full Text] [Related]
31. Non-motor Symptoms in Chinese Patients With Isolated Generalized Dystonia: A Case-Control Study. Li S; Wang L; Yang Y; Qiao L; Zhang D; Wan X Front Neurol; 2020; 11():209. PubMed ID: 32322234 [No Abstract] [Full Text] [Related]
32. The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: a simple grading system. Chaudhuri KR; Sauerbier A; Rojo JM; Sethi K; Schapira AH; Brown RG; Antonini A; Stocchi F; Odin P; Bhattacharya K; Tsuboi Y; Abe K; Rizos A; Rodriguez-Blazquez C; Martinez-Martin P Parkinsonism Relat Disord; 2015 Mar; 21(3):287-91. PubMed ID: 25616694 [TBL] [Abstract][Full Text] [Related]
33. Gender and onset age related-differences of non-motor symptoms and quality of life in drug-naïve Parkinson's disease. Hu T; Ou R; Liu H; Hou Y; Wei Q; Song W; Cao B; Chen Y; Yuan X; Shang H Clin Neurol Neurosurg; 2018 Dec; 175():124-129. PubMed ID: 30408646 [TBL] [Abstract][Full Text] [Related]
34. Nonmotor symptoms in primary adult-onset cervical dystonia and blepharospasm. Yang J; Shao N; Song W; Wei Q; Ou R; Wu Y; Shang HF Brain Behav; 2017 Feb; 7(2):e00592. PubMed ID: 28239516 [TBL] [Abstract][Full Text] [Related]
35. Myoclonus-dystonia: Distinctive motor and non-motor phenotype from other dystonia syndromes. Timmers ER; Smit M; Kuiper A; Bartels AL; van der Veen S; van der Stouwe AMM; Santens P; Bergmans B; Tijssen MAJ Parkinsonism Relat Disord; 2019 Dec; 69():85-90. PubMed ID: 31706131 [TBL] [Abstract][Full Text] [Related]
36. Effects of MAO-B inhibitors on non-motor symptoms and quality of life in Parkinson's disease: A systematic review. Tsuboi T; Satake Y; Hiraga K; Yokoi K; Hattori M; Suzuki M; Hara K; Ramirez-Zamora A; Okun MS; Katsuno M NPJ Parkinsons Dis; 2022 Jun; 8(1):75. PubMed ID: 35697709 [TBL] [Abstract][Full Text] [Related]
37. Relationship between higher rates of adverse events in deep brain stimulation using standardized prospective recording and patient outcomes. Burdick AP; Fernandez HH; Okun MS; Chi YY; Jacobson C; Foote KD Neurosurg Focus; 2010 Aug; 29(2):E4. PubMed ID: 20672921 [TBL] [Abstract][Full Text] [Related]
38. Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease. Dafsari HS; Weiß L; Silverdale M; Rizos A; Reddy P; Ashkan K; Evans J; Reker P; Petry-Schmelzer JN; Samuel M; Visser-Vandewalle V; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L; Brain Stimul; 2018; 11(4):867-874. PubMed ID: 29655587 [TBL] [Abstract][Full Text] [Related]